Trevi Therapeutics (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.
Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.
ServiceTitan (TTAN) stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.
Over 2.94 million shares of the company traded intraday.
Liquidity Services (LQDT) shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.
Almost 956,000 shares traded intraday compared with a daily average of about 117,000.
Price: 4.33, Change: +1.84, Percent Change: +73.86
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。